Implications of genetic testing for the insurance industry: The UK example

Community Genetics

Volumn 5, Issue 2, 2002, Pages 102-109

  Raeburn, Sandy ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Access to life and other insurances; Adverse selection (anti selection); Genetically disadvantaged; Predictive values of genetic tests

Indexed keywords

GENETIC DISORDER; GENETIC PROCEDURES; GENETIC RISK; HEALTH INSURANCE; HUMAN; MEDICAL ETHICS; MEDICAL GENETICS; MEDICAL PRACTICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL SECRECY; REVIEW; UNITED KINGDOM;

ASSOCIATION OF BRITISH INSURERS; GENETICS AND INSURANCE COMMITTEE (GREAT BRITAIN); GENETICS AND REPRODUCTION; HUMAN GENETICS COMMISSION (GREAT BRITAIN);

ADVISORY COMMITTEES; DISCLOSURE; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; GENETIC PRIVACY; GENETIC SCREENING; GREAT BRITAIN; HUMANS; INSURANCE; INSURANCE SELECTION BIAS; INSURANCE, HEALTH; INSURANCE, LIFE; PREDICTIVE VALUE OF TESTS; SOCIAL CONTROL POLICIES;

EID: 0036970655     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065168     Document Type: Review

References (39)

1. Babbage C: A Comparative View of the Various Institutions for the Assurance of Lives. 1826. Printed for J. Mawman, Ludgate Street, London.
2. Brackenridge RDC, Elder WJ (eds): Medical Selection of Life Risks, ed 4. Oxford, Macmillan, 1998.
3. Young ID: Introduction to Risk Calculation in Genetic Counselling, ed 2. Oxford, Oxford University Press, 1999.
4. Lowden JA: Underwriting genetic diseases; in Brackenridge RDC, Elder WJ (eds): Medical Selection of Life Risks, ed 4. Oxford, Macmillan, 1998, pp 89-102.
5. Macdonald AS: How will improved forecasts of individual lifetimes affect underwriting? Philos Trans R Soc Lond B Biol Sci 1997;352:1067-1075.
6. Simpson SA, Besson J, Alexander A, Allan K, Johnston AW: One hundred requests for predictive testing for Huntington's disease. Clin Genet 1992;41:326-330.
7. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, et al: Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 1993;4:387-392.
8. Claes S, Van Zand K, Legius E, Dom R, Malfroid M, Baro F, Godderis J, Cassiman JJ: Correlations between triplet repeat expansion and clinical features in Huntington's disease. Arch Neurol 1995;52:749-753.
9. Association of British Insurers: ABI Genetics Code of Practice. London, Association of British Insurers, 1997.
10. Association of British Insurers: ABI Genetics Code of Practice. London, Association of British Insurers, 1999.
11. Harper PS: Genetic testing, life insurance, and adverse selection. Philos Trans R Soc Lond B Biol Sci 1997;352:1063-1066.
12. Kitcher P: The Lives to Come. The Genetic Revolution and Human Possibilities. London, Penguin, 1996.
13. Hall GH, Hamilton WT: Genetic testing and insurance. Withholding test results sidesteps ethical problems. BMJ 1994;308:472-473.
14. McKeand JGL: The Insurance Industry and New Genetics; in Walpole I, Durstan B, Moore D (eds): Proceedings of the Lecture Series: Community and the New Genetics. Perth, Health Department of Western Australia, 1996, pp 19-29.
15. Leigh S: The Freedom to Underwrite. Meet Staple Inn Actuarial Society, London, Jan 1996. London, Staple Inn Actuarial Society, 1996.
16. Murthy A, Dixon A, Mossialos E: Genetic testing and insurance. J R Soc Med 2001;94:57-60.
17. Nuffield Council on Bioethics: Genetic screening: Ethical issues. London, Nuffield Council on Bioethics, 1993.
18. Select Committee: Human Genetics: The Science and Its Consequences. Science and Technology Select Committee, House of Commons, Third Report. 1994-95 Session. Lon-don, 1996.
19. The Alzheimer's Society submission to Science and Technology Committee 2001, Appendix 15 of the Fifth Report, Science and Technology Committee 2000-2001, pp 57-66.
20. Kent A: Putting the genetics genie back into its bottle. BMJ 2001;322:1070.
21. Warren V (ed): Genetic Tests and Future Need for Long-Term Care in the UK. Report of a Work Group of the Continuing Care Conference. London, Continuing Care Conference, 1999.
22. UK FGI see website http://www.ukfgi.org.uk
23. Raeburn JA: Clinical aspects of genetics and insurance. The development and roles of Codes of Practice; in McGleenan T, Wiesing U, Ewald F (eds): Insurance and Genetics. Oxford, BIOS, 1999, pp 105-114.
24. Human Genetics Advisory Commission Report: The implications of genetic testing for Insurance. London, HGAC, 1997.
25. Government Response to the Human Genetics Advisory Commission's Report on The Implications of Genetic Testing for Insurance. London, Department of Trade and Industry, Office of Science and Technology, Department of Health 1998.
26. Genetics and Insurance Committee: First Annual Report, April 1999-June 2000. London, Department of Health, 2000.
27. A MORI Poll document. Public attitudes to human genetic information. People's Panel Quantitative Study conducted for the Human Genetics Commission. Human Genetics Commission, London, Feb 2001.
28. Genetics Commission: Whose hands on your genes? A discussion document on the storage, protection and use of personal genetic information. Human Genetics Commission, London, Nov 2000.
29. Genetics Commission: Debating the ethical future of human genetics. First Annual Report of the Human Genetics Commission. Human Genetics Commission, London, Sept 2001. website: http://www.hgc.gov.uk
30. Bobrow M, in Science and Technology Fifth Report, session 2000-2001, Minutes of Evidence, pp 1-12.
31. Genetics and Insurance. Select Committee on Science and Technology Fifth Report, 2000-2001 Session. London, March 2001.
32. Government Response to the Report from the House of Commons Science and Technology Committee: Genetics and Insurance. London, Department of Health, The Stationery Office, 2001.
33. Harper PS, Newcombe RG: Age at onset and life table risks in genetic counselling for Huntington's Disease. J Med Genet 1982;29:239-242.
34. Brinkman RR, Mezei MM, Theilman J, Alm-quist E, Hayden MR: The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 1997;60:1202-1210.
35. Raeburn JA: The impact of advances in genetics on medicine and healthcare funding. Proc 17th Int Fed Health Funds Conf, Cape Town, March 1998, pp 247-283.
36. Raeburn JA: Genetic tests and insurance in the UK. Reform, Australian Law Reform Commission 2001, pp 32-36.
37. Genetic Interest Group submission to the Science and Technology Fifth Report, 2001, pp 68-70.
38. McGleenan T: Insurance and Genetic Information. London, Association of British Insurers, 2001.
39. Huntington's Disease Association submission to the Science and Technology Fifth Report, 2001, pp 74-75.